Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and SCAN domain-containing protein 5A (ZSCAN5A) is a member of the zinc finger protein family, characterized by C2H2-type zinc finger motifs and a SCAN domain[3][5]. ZSCAN5A functions as a sequence-specific DNA-binding transcription factor predicted to regulate transcription by RNA polymerase II[3]. Like other zinc finger transcription factors, it likely participates in a range of cellular processes including gene regulation, differentiation, and chromatin organization[1][3][6]. ZSCAN5A is encoded by the ZSCAN5A gene and is mainly localized in the nucleus[3]. Though its precise biological and pathological roles are not fully elucidated, mutations and altered expression of related zinc finger proteins have been associated with diverse diseases, notably cancer, but ZSCAN5A itself is not currently an established drug target or widely recognized clinical biomarker[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and SCAN domain-containing protein 5A (ZSCAN5A).